Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT02372578

Public ClinicalTrials.gov record NCT02372578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Randomized, Double-Blind, Multicenter, Placebo and Active Controlled Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT02372578
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
115 participants

Conditions and interventions

Interventions

  • ASP3662 Drug
  • ASP3662 placebo Drug
  • pregabalin Drug
  • pregabalin placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 26, 2015
Primary completion
May 19, 2016
Completion
May 19, 2016
Last update posted
Mar 25, 2019

2015 – 2016

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Site US10001 Anniston Alabama 36207
Site US10039 Phoenix Arizona 85023
Site US10054 Fresno California 93720
Site US10020 Lomita California 90717
Site US10047 Santa Monica California 90404
Site US10017 Tustin California 92780
Site US10055 Walnut Creek California 94598
Site US10053 Fairfield Connecticut 06824
Site US10005 Boynton Beach Florida 33436
Site US10023 Bradenton Florida 34205
Site US10018 Clearwater Florida 33765
Site US10019 DeLand Florida 32720
Site US10004 Homestead Florida 33030
Site US10042 Jacksonville Florida 32256
Site US10007 Jupiter Florida 33458
Site US10041 Miami Lakes Florida 33014
Site US10046 Orlando Florida 32806
Site US10008 Ormond Beach Florida 32174
Site US10003 Oviedo Florida 32765
Site US10049 The Villages Florida 32162
Site US10009 Aurora Illinois 60506
Site US10036 Chicago Illinois 60624
Site US10025 Evansville Indiana 47714
Site US10064 Metairie Louisiana 70006
Site US10051 Boston Massachusetts 02115
Site US10026 New Bedford Massachusetts 02740-2133
Site US10063 Quincy Massachusetts 02169
Site US10043 Hazelwood Missouri 63042
Site US10013 Kettering Ohio 45429
Site US10014 Duncansville Pennsylvania 16635
Site US10015 Greer South Carolina 29651
Site US10034 Austin Texas 78731
Site US10040 Houston Texas 77030
Site US10032 San Antonio Texas 78218
Site US10031 San Antonio Texas 78228
Site US10033 Salt Lake City Utah 84107
Site US10045 Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02372578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2019 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02372578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →